Skip to main content
Contact Us
search

Author Biography

Christie.Teigland@inovalon.com
Connect on LinkedIn

Christie Teigland, PhD

Vice President, Research Science and Advanced Analytics

Christie leads the design and implementation of studies focused on quality performance measure development and testing, health disparities and equity, predictive analytics, comparative effectiveness, health economics and outcomes research, and treatment pattern analyses.

Christie works with health plans, providers, and life science organizations to provide actionable real world data insights. She serves as co-chair of the National Quality Forum (NQF) Scientific Methods Panel and is a member of the Pharmacy Quality Alliance (PQA) Quality Measure Expert Panel. She has served as principal investigator on numerous performance measure development projects, including several awarded by the National Committee on Quality Assurance (NCQA) for All-Cause 30-Day Readmissions and Potentially Avoidable Hospitalizations.

Prior to joining Inovalon, Christie specialized in quality and patient safety research at Leading Age New York where she directed the development of innovative technology solutions to advance the use of electronic data-driven decision-making tools in long term care settings. Christie earned a PhD. in Economics and Econometric Forecasting from the University of New York at Albany and a B.A. in Management Science and Economics from Moorhead State University.

Authored Content

Filter

May 21, 2023
Presentation

Measuring the Value and Return on Investment of Health Insurers Providing Non-Medical Benefits to Support Social Determinants of Health and Other Social Risk Factors

Teigland C, Bilder S
Accepted for presentation at Pharmaceutical Management Science Association (PMSA) 2023 Annual Conference. Findings available upon request. Contact us for more information.
Read More
May 21, 2023
Presentation

Development of a Social Determinants of Health Insights Dashboard to Support Organizations in Advancing Health Equity

Teigland C, Kilgore K
Accepted for presentation at Pharmaceutical Management Science Association (PMSA) 2023 Annual Conference. Findings available upon request. Contact us for more information.
Read More
May 13, 2023
Presentation

Impact of Availability and Distance to Device Aided Therapy Services for Medicare Fee-for-Service Beneficiaries with Advanced Parkinson’s Disease

Yan C, Silverstein A, Schinkel J, Teigland C, Strezewski J, Kukreja P, Shah M, Kandukuri K, Shewale A, Shahed JJ, Fernandez H
Accepted for presentation at International Association of Parkinsonism and Related Disorders (IAPRD), World Congress 2023. Findings available upon request. Contact us for more information.
Read More
May 7, 2023
Presentation

Impact of Social Determinants of Health on Access to Device Aided Therapy Services for Medicare Fee-for-Service Beneficiaries with Advanced Parkinson’s Disease

Teigland C, Silverstein A, Schinkel J, Yan CH
Accepted for presentation at ISPOR 2023. Findings available upon request. Contact us for more information.
Read More
May 7, 2023
Presentation

Characteristics, Healthcare Resource Utilization, Cost, and Quality Outcomes of Medicare Beneficiaries While Commercially Insured Before and After Transition to Medicare Advantage or Traditional Medicare Fee-for-Service

Teigland C, Pulungan Z, Mohammadi I, Jones B, Bilder S, Brot-Goldberg Z, Su Y, Vabson B
Accepted for presentation at ISPOR 2023. Findings available upon request. Contact us for more information.
Read More
May 3, 2023
Poster Presentation

Impact of Social Determinants of Health on Access to Device Aided Therapy Services for Medicare Fee-for-Service Beneficiaries with Advanced Parkinson’s Disease

Connie H. Yan, Alison R. Silverstein, Jill Schinkel, Christie Teigland
This study examined APD patient characteristics including near-neighborhood-level SDOH based on residence 9-digit ZIP-code to understand the impact of SDOH on DAT receipt.
Read More
May 3, 2023
Poster Presentation

Characteristics, Healthcare Resource Utilization, Cost, and Quality Outcomes of Medicare Beneficiaries While Commercially Insured Before and After Transition to Medicare Advantage or Traditional Medicare Fee-for-Service

Boris Vabson, Zulkarnain Pulungan, Zarek Brot-Goldberg, Yalun Su, Iman Mohammadi, Barton Jones, Christie Teigland
This study provides a first look at demographic, clinical, and social risk characteristics of individuals who select MA versus FFS while covered by commercial insurance prior to turning age 65 and compares healthcare outcomes before and after enrolling.
Read More
March 7, 2023
Peer-Reviewed Article

Z Codes Can Provide Important Data on Social Determinants of Health and Improve Care: How Can We Improve Utilization?

Patient social determinants of health (SDOH) are defined as “the conditions in the environments where people are born, live, learn, work, play, worship, and age that affect a wide range of health, functioning, and quality-of-life outcomes and risks.” Over the past decade, there has been increasing recognition of the important role of SDOH on health and health-related outcomes such as hospital admissions and readmissions, length of stay, emergency room visits, and use of post-acute care services.,, Addressing SDOH has been associated with better access to and engagement in health care, as well as improved health outcomes and lower costs. 
Read More